Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.
Microbes, collectively, include bacteria, viruses, fungi, and parasites. For the past 70 years, antimicrobial drugs, such as antibiotics, have been successfully used to treat patients with bacterial and infectious diseases. Over time, however, many infectious organisms have adapted to the drugs designed to kill them, making the products less effective. To address this growing problem, NIAID is funding and conducting research on many aspects of antimicrobial (drug) resistance, including basic research on how microbes develop resistance, new and faster diagnostics, and clinical trials designed to find new vaccines and treatments effective against drug-resistant microbes.
Media Availability: NIH Scientists Discover Promising Target to Block Staphylococcus Infection—Feb. 11, 2013
Media Availability: Genomes Show How Staph Bacteria Gain Resistance to Last-Line Drug—May 22, 2012
Media Availability: NIH Scientists Link Quickly Spreading Gene to Asian MRSA Epidemic—April 22, 2012
NIAID Now Seeking Applications to Establish a Leadership Group for a New Clinical Research Network Focused on Antibacterial Resistance—Jan. 17, 2012
Last Updated June 29, 2012
Last Reviewed April 13, 2011